<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref154">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wasserman</surname>
    <given-names>R. L.</given-names>
   </name>
   <name>
    <surname>Greener</surname>
    <given-names>B. N.</given-names>
   </name>
   <name>
    <surname>Mond</surname>
    <given-names>J.</given-names>
   </name>
  </person-group> (
  <year>2017</year>). 
  <article-title>RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations</article-title>. 
  <source>Expert Rev. Clin. Immunol.</source>
  <volume>13</volume>, 
  <fpage>1107</fpage>â€“
  <lpage>1119</lpage>. 
  <pub-id pub-id-type="doi">10.1080/1744666X.2017.1389647</pub-id>, PMID: 
  <?supplied-pmid 29035131?>
  <pub-id pub-id-type="pmid">29035131</pub-id>
 </mixed-citation>
</ref>
